Navigation Links
Stem cell transplants improve recovery in animal models for stroke, cerebral palsy

core," Dr. Borlongan said. "But outside of that core there is a lining, what we call the penumbra, and that penumbra, if you do not treat it over time, becomes part of the core. We are showing, that even one week after a stroke, we are able to increase the number of cells surviving along that penumbra and that is how we feel it is producing significant recovery, by rescuing cells within the penumbra."

Animals in the model of cerebral palsy, a condition caused by an ischemic injury similar to stroke but occurring before or during birth, also experienced at least a 25 percent improvement over controls. Rodent stem cells were used in this model, a larger percent of donated cells survived and within two weeks matured into neurons in the young, more pliable brains, Dr. Borlongan said. Also, close donor matching seemed unnecessary. Unmatched transplants, from the same species, and gentically identical transplants yielded essentially equal results.Athersys, Inc., a Cleveland-based biopharmaceutical company pursuing cell therapy programs in cardiovascular disease, stroke, cancer and other diseases, funded the research in which previously frozen human or rodent multipotent adult progenitor cells, which the company calls MultiStemTM, were thawed and injected directly into the brain.

Researchers believe that MultiStemTM cells are able to deliver a therapeutic benefit in multiple ways, for example by producing factors that limit tissue damage and stimulate repair, according to Dr. Gil Van Bokkelen, the company's chairman and chief executive officer. In addition, MultiStemTM cells can safely mature into a broad range of cell types and can be produced on a large scale, something which should ease the move toward clinical studies and eventual clinical use. "Given the number of stroke victims each year, it would be a big step forward if a safe and effective stem cell therapy could be produced, conveniently stored, and
'"/>

Source:Medical College of Georgia


Page: 1 2 3 4 5

Related biology news :

1. Pennsylvania researchers find liver transplants provide metabolic cure for rare genetic disease
2. Predicting successful outcomes in living-donor liver transplants
3. What animals can tell us about hemorrhage, organ transplants and aging
4. Leading reason for corneal transplants comes into focus
5. Protein may hold key to decreasing organ dysfunction rates in heart transplants
6. Stem cell transplants explored at Stanford as a possible treatment for hearing loss
7. Thymus transplants gives hope to babies with fatal immune disease
8. Discovery of key proteins shape could lead to improved bacterial pneumonia vaccine
9. Novel ultrafast laser detection of cancer cells also may improve understanding of stem cells
10. Vascular structure and function improve with diet and exercise
11. Scientists discuss improved biopesticides for locust control in West Africa

Post Your Comments:
(Date:12/2/2009)...the National Institute of Health, 40 percent to 45...ady have some stage of diabetic retinopathy. Diab...eaky blood vessels, is a major cause of blindness ...red diabetic complications. In fact, up to 80 per...ars or more will experience some form of diabetic ...
(Date:12/1/2009)...ewswire/ -- GestureTek Inc. today announced the la...e, plug and play interactive projection display sy...touring promotions. GestureTek is the inventor and...ture recognition technology for interactive displa...uaranteed for quality, the CUBE has TUV, CE, CSA a...
(Date:12/1/2009)...en awarded a U.S. Air Force Center of Excellence t...adaptive materials, and to develop tools to optimi...ighter. , The $10.5 million Center, known as th...s and Improved Cognition (BIONIC) center, is being...fessors in Georgia Tech,s School of Materials Scie...
Breaking Biology News(10 mins):Study shows pine bark improves circulation, swelling and visual acuity in early diabetic retinopathy 2Study shows pine bark improves circulation, swelling and visual acuity in early diabetic retinopathy 3GestureTek Unveils The CUBE V3 Portable, Plug and Play Interactive Projection Display System for Advertising and Exhibits 2Air Force Center of Excellence awarded in nanostructures and improved cognition 2Air Force Center of Excellence awarded in nanostructures and improved cognition 3Air Force Center of Excellence awarded in nanostructures and improved cognition 4EUCODIS Bioscience Appoints Bhupinder Hundle to Senior Vice President Marketing 26amp 3B Sales 5378 1EUCODIS Bioscience Appoints Bhupinder Hundle to Senior Vice President Marketing 26amp 3B Sales 5378 2EUCODIS Bioscience Appoints Bhupinder Hundle to Senior Vice President Marketing 26amp 3B Sales 5378 3A Little Cash Buys a Lot of Calories at the Corner Store 59282 1A Little Cash Buys a Lot of Calories at the Corner Store 59282 2Proteolix Inc to be Acquired By Onyx Pharmaceuticals 59278 1Proteolix Inc to be Acquired By Onyx Pharmaceuticals 59278 2Proteolix Inc to be Acquired By Onyx Pharmaceuticals 59278 3Proteolix Inc to be Acquired By Onyx Pharmaceuticals 59278 4
... in the Arctic has shrunk to its lowest level this... years ago, opening up the Northwest Passage a lo...as been historically impassable. , In the mosaic ...ed in early September 2007 by the Advanced Synthet...visat satellite, the dark gray colour represents t...
..., 2007 One of the 2007 American Society for Microb...ored by ASM will be presented to Hung Ton-That, Ph...cular, Microbial, and Structural Biology, Universi...being honored for his research excellence in micro... research is highly regarded, and has been publish...
...ale skeleton excavated 20 years ago amid the stenc... on California,s A o Nuevo Island turns out to be ...sil whale fall and the first in California, accord...ologists. , Whale falls, first recognized in the ...cean floor where, like an oasis in the desert, the...
Other Biology News:Satellites witness lowest Arctic ice coverage in history 2Ancient whale fall from California's Ao Nuevo Island one of youngest, most complete known 2Ancient whale fall from California's Ao Nuevo Island one of youngest, most complete known 3
(Date:12/1/2009)...CLINE VILLAGE, Nev., Dec. 1 /PRNewswire-FirstCall/...ay announced revenue guidance for the fourth quart...llion, as compared with $69 million for the fourth...results was the first of two installment payments ...ourth quarter 2008 results was a one-time $1.8 mil...
(Date:12/1/2009)... , CAMBRIDGE, Mass., Dec. 1 To ...ustry and to promote its potential, a group of ind...the Synthetic Biology Industry Association (SynBIA...of the association is to provide a forum for indiv... industry, address its opportunities and its chall...
(Date:12/1/2009)...AN FRANCISCO, Dec. 1 The Burrill B...lf the value it lost in October. The Select,s gain...t month for the general markets with the Dow up 6....The gains held firm in the final two trading days ...sh Thanksgiving holiday shopping and Dubai,s repor...
(Date:12/1/2009)... , SAN DIEGO, Dec. 1 /PRNewswire-FirstCall/ -... announced today that it will present at the LD MI...00 p.m. (PST) at the Luxe Hotel in Los Angeles. Ae...will present a corporate overview and will provide...its lead product, the Hemopurifier®, a first-...
Breaking Biology Technology:PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 2PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 3Industry Forms Association to Address Opportunities and Challenges of Synthetic Biology 2Biotech Gets Back on Track in November 2Biotech Gets Back on Track in November 3Biotech Gets Back on Track in November 4Aethlon Medical to Present at LD MICRO Conference on December 3, 2009 2
...ion with Kentucky Bioprocessing for future-oriente...Ky., Sept. 29 Bayer,Innovation GmbH and Kentucky ...lop a facility at KBP,s Owensboro plant in the US ...opharmaceuticals. Based on Bayer,s proprietary,mag...teins (PMP) and other,high-value products will be ...
... Sept. 29 Cell Therapeutics, Inc.,("CTI" or the "...nounced that,a single institutional investor shall...onvertible Senior Notes due 2012, with a conversio... result of an amendment of a,September 15, 2008 ag...hich,the investor had purchased $9 million of seni...
...S, Md., Sept. 26 PharmAthene, Inc.,(Amex: PIP ),...asures,against biological and chemical threats, an...gy and Infectious Diseases (NIAID), part of the Na... Company a multi-year contract,for up to $83.9 mil...n,recombinant protective antigen (rPA) anthrax vac...
Other Biology Technology:Bayer Broadens Its Manufacturing Basis for Biopharmaceuticals in Tobacco Plants 2Bayer Broadens Its Manufacturing Basis for Biopharmaceuticals in Tobacco Plants 3Bayer Broadens Its Manufacturing Basis for Biopharmaceuticals in Tobacco Plants 4Cell Therapeutics, Inc. Announces Single Institutional Investor Purchases $14.2 Million of Senior Convertible Notes 2Cell Therapeutics, Inc. Announces Single Institutional Investor Purchases $14.2 Million of Senior Convertible Notes 3PharmAthene Awarded NIAID Contract For Up to $83.9 Million For Third Generation rPA Anthrax Vaccine Program 2PharmAthene Awarded NIAID Contract For Up to $83.9 Million For Third Generation rPA Anthrax Vaccine Program 3PharmAthene Awarded NIAID Contract For Up to $83.9 Million For Third Generation rPA Anthrax Vaccine Program 4PharmAthene Awarded NIAID Contract For Up to $83.9 Million For Third Generation rPA Anthrax Vaccine Program 5PharmAthene Awarded NIAID Contract For Up to $83.9 Million For Third Generation rPA Anthrax Vaccine Program 6
Mouse Anti-Bacteria RNA polymerase sigma 70 Monoclonal Antibody, Unconjugated, Clone 2G10 from ABR-Affinity BioReagents
Rat Anti-UGGT Monoclonal Antibody, Unconjugated from Abcam
LC/MSD TOF from Agilent Technologies
Mouse Anti-Human LAT, phospho (Tyr226) Monoclonal Antibody, Unconjugated, Clone J96-1238.58.93 from BD Biosciences Pharmingen
Biology Products: